Company
introduction

ICM pursues novel therapeutic solutions
for incurable diseases

Company

Management Team

An experienced team
with global competitiveness

Dae-Won Kim, Ph.D.

Founder, Chief Executive Officer

  • Professor, Yonsei University, Dept. Biochemistry
  • Postdoc, Harvard Medical School
  • PhD, Tufts Medical School
  • BS, MS, Yonsei University
Korean Society of Gene and Cell Therapy
- President (2023-2024) / Board Member (2023-Present)
Korean Society of Cartilage and Osteoarthritis
- President (2025) / Vice President (2024) / Board Member (2017-Present)
Regenerative Medicine Acceleration Foundation
- Board Member (2023-2024)
Osong Medical Innovation Foundation
- Board Member (2025-2028)
[Ministry of Health and Welfare] Advanced Regenerative Medicine and Advanced Biological Products Specialized Committee
- Committee Member (2022-2023)
[Ministry of Health and Welfare] Central Pharmaceutical Affairs Council
- Committee Member (2024-2026)
[Ministry of Science and ICT] Advanced Biotechnology Coordination Committee
- Committee Member (2023-2027)
[Office for Government Policy Coordination] National Industry-Academia-Research Cooperation Committee
- Committee Member (2023-2025)

Jay Myung Ph.D.

President, Chief Operating Officer

  • Executive Consultant, Korea Health Industry Development Institute
  • Executive Vice President, Boryung Pharmaceutical Inc.
  • Associate Director, BioRelix, Inc
  • Senior Research Scientist, Bayer Pharmaceuticals
  • Anderson Postdoctoral Fellow and NIH NRSA Postdoctoral Fellow, Yale University
  • Ph.D., Brandeis University

Young-Na Yum Ph.D.

Executive Vice President,
Chief Clinical Development Officer

  • Deputy Director, NITR/KFDA Korea
  • Postdoc, The Burnham Institute
  • Deputy Director, NIFDS/MFDS Korea
  • BS, MS, PhD, Yonsei University

Daegun Kim Ph.D.

Executive Vice President, Chief Manufacturing Officer

  • Director of R&D Planning, Hugel
  • Technologies manager, Kimberly-Clark Innovation Center Asia
  • Postdoc, Harvard Medical School
  • PhD, Seoul National University

Heui-Young Ryu D.Sc.

Executive Vice President, Chief Quality Officer

  • Deputy Director, MFDS Korea
  • MS, DSc, Boston University, School of Public Health
  • MS, Seoul National University, Graduate School of Public Health

Minsun Park Ph.D.

Vice President, Research & Development Department

  • Research Assistant Professor, Yonsei University, College of Medicine Institute of Behavioral Science in Medicine
  • PhD, Yonsei University

Sunmin Hwang CPA

Vice President, Management Department

  • Director, Charm Accounting Corp.
  • Manager, Ernst & Young Hanyoung
  • Certified Public Accountant
  • BBA, Korea University

Barbara Thorne Ph.D.

Senior Director, CMC

  • Celladon Corporation
  • Targeted Genetics Corp.
  • Xcyte Therapies

Alison Heald M.D.

Senior Director, Clinical Development

  • University of Washington Medical Center
  • Targeted Genetics Corp.
  • Sarepta Therapeutics